IMDX
Insight Molecular Diagnostics Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.89
−3.99%Oct 14, 2026, 12:00 UTC
Insight Molecular Diagnostics Inc. appointed Donnie Purto as Senior Vice President of Sales.
Source:Sep 21, 2026, 20:11 UTC
Insight Molecular Diagnostics Inc. amended its merger agreement with Chronix to replace earnout consideration with a 10% royalty on CNI Monitor sales, payable until a CNI Monitor sale or IP expiration.
Jul 16, 2026, 19:22 UTC
Insight Molecular Diagnostics Inc. highlighted a favorable new Medicare policy that expands coverage for donor-derived cell-free DNA testing in transplant care.
Source: